The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...